Feed JNJ
JN

Johnson & Johnson

JNJ · NYSE

$267.58 -1.61% (-$4.37)
1M +2.29%
Market Cap $649.5B
P/E Ratio 30.87x
Div. Yield 1.96%
ROE 25.74%

Bulios Fair Price

$272.75

1.9% upside

Current Price

$267.58

Undervalued Fair Value Overvalued

According to Bulios Fair Price, JNJ is currently trading close to its fair value. How does it work?

Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?

Analysis

An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.

Piotroski F-Score Strong
8/9
Valuation
33 /100
Expensive
P/E 30.87x
EV/EBITDA 20.10x
PEG 0.27x
Growth
57 /100
Stable
EPS growth 17.90%
Rev. growth 5.60%
Book val. growth 2.02%
Profitability
100 /100
Strong
Gross margin 70.45%
Net margin 21.48%
FCF margin 19.10%
Quality
79 /100
Excellent
ROIC 13.89%
ROE 25.74%
Asset turnover 0.49x
Debt
81 /100
Low
Debt/Equity 0.58x
Current ratio 1.09x
Net debt/EBITDA 0.85x
Stability
47 /100
Moderate
Beta 0.24x
Rev. volatility 1.15%
Profitable years 6

Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more

Ask StockBot about JNJ
Online

About the company

Johnson & Johnson (JNJ) is a global pharmaceutical, medical, and consumer goods manufacturing company with a diverse portfolio of products. For over 130 years, they have been delivering innovative medicines, medical devices, and consumer products that improve people's lives worldwide. With a strong market position and a history of consistent dividend growth, Johnson & Johnson stock is attractive to conservative investors seeking stable and income-generating returns. Add JNJ stock to your watchlist on Bulios and stay informed about the latest news and innovations from this established company.

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Joaquin Duato

Employees

141,700

Headquarters

New Brunswick

Upcoming events

13 OCT

Earnings

Upcoming earnings report

13d

We use essential cookies to run the website and optional analytics cookies to measure usage. See our Privacy Policy.